Results 41 to 50 of about 1,282,638 (192)
Nicotinic Acetylcholine Receptors Assembled from the α7 and β3 Subunits [PDF]
Intracellular recordings were performed in voltage-clamped Xenopus oocytes upon injection with a mixture of cDNAs encoding the beta3 and mutant alpha7 (L247Talpha7) neuronal nicotinic acetylcholine receptor (nAChR) subunits. The expressed receptors maintained sensitivity to methyllycaconitine and to alpha-bungarotoxin but exhibited a functional profile
PALMA, Eleonora +4 more
openaire +4 more sources
Structure-Function Studies of Nicotinic Acetylcholine Receptors Using Unnatural Amino Acids [PDF]
This dissertation primarily describes structure-function studies of the nicotinic acetylcholine receptors (nAChRs). These studies use a combination of unnatural amino acid mutagenesis and electrophysiology to determine the specific molecular interactions
Puskar, Nyssa Leigh
core +1 more source
Allenamides Playing Domino: A Redox‐Neutral Photocatalytic Synthesis of Functionalized 2‐Aminofurans
Abstract A photoredox catalytic synthesis of functionalized 2‐aminofurans is proposed starting from α‐halo carbonyl substrates and N‐allenamides. The protocol proves to be efficient and sustainable thanks to: i) the use of visible light as green energy source, ii) the redox‐neutral nature of the transformation, allowing to avoid additives and strong ...
Arianna Quintavalla +6 more
wiley +1 more source
Neuronal nicotinic receptors as new targets foramphetamine-induced oxidative damage and neurotoxicity [PDF]
Amphetamine derivatives such as methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are drugs widely abused in a recreational context.
Pubill Sánchez, David +7 more
core +1 more source
Alzheimer's disease drug development pipeline: 2022
Abstract Introduction Alzheimer's disease (AD) represents a global health crisis. Treatments are needed to prevent, delay the onset, slow the progression, improve cognition, and reduce behavioral disturbances of AD. We review the current clinical trials and drugs in development for the treatment of AD.
Jeffrey Cummings +6 more
wiley +1 more source
Discovery of the Nicotinic Receptor Toxin Anabaseine in a Polystiliferan Nemertean
Nemerteans (also called Nemertines) are a phylum of predominantly marine worms that use toxins to capture prey and to defend themselves against predators.
William R. Kem +3 more
doaj +1 more source
Proteomic Analysis of an α7 Nicotinic Acetylcholine Receptor Interactome [PDF]
The alpha7 nicotinic acetylcholine receptor (nAChR) is well established as the principal high-affinity alpha-bungarotoxin-binding protein in the mammalian brain. We isolated carbachol-sensitive alpha-bungarotoxin-binding complexes from total mouse brain tissue by affinity immobilization followed by selective elution, and these proteins were ...
Joao A, Paulo +2 more
openaire +2 more sources
Nicotine addiction : a review [PDF]
Nicotine, the major psychoactive compound in tobacco, acts as a potent addictive drug in humans. The addictive nature of nicotine leads to more than 6 million deaths a year.
Di Giovanni, Giuseppe, Vella, Jacob
core +1 more source
CHRNA7, encoding the neuronal alpha7 nicotinic acetylcholine receptor (a7nAChR), is highly expressed in the brain, particularly in the hippocampus. It is situated in the 15q13.3 chromosome region, frequently associated with a Copy Number Variation (CNV),
Elisa Maria Turco +13 more
doaj +1 more source
Scanning curves and kinetics of the acetylcholine/acetylcholine receptor hysteresis [PDF]
Neumann E, Boldt E, Rauer B, Wolf H, Chang HW. Scanning curves and kinetics of the acetylcholine/acetylcholine receptor hysteresis. Bioelectrochemistry and Bioenergetics.
Hendrik Wolf +9 more
core +1 more source

